A case report of pancreatic tuberculosis: arterial infusion of isoniazid as an adjunct to oral antituberculosis medications has demonstrated promising therapeutic efficacy.

A case report of pancreatic tuberculosis: arterial infusion of isoniazid as an adjunct to oral antituberculosis medications has demonstrated promising therapeutic efficacy.

Publication date: Nov 17, 2025

Isolated pancreatic tuberculosis is a rare manifestation of Mycobacterium tuberculosis infection in the human body. A 35-year-old male presented at our medical center with upper abdominal distension and pain. Pre- and post-admission Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) scans revealed a pronounced ring-enhanced mass at the head of the pancreas, compressing the adjacent common bile duct. Initially, the radiologist misdiagnosed the mass as a pancreatic neuroendocrine tumor. The patient had no known history of tuberculosis exposure, and the tuberculin skin test demonstrated a positive result. The lesion was ultimately identified as a pancreatic tuberculous granuloma through endoscopic ultrasound-guided fine needle aspiration. Given the granuloma’s rich arterial blood supply, we performed artery cannulation and locally infused isoniazid to reduce the patient’s abdominal pain. The patient then began antitubercular therapy (ATT) The patient’s epigastric pain resolved within 3 days post-regional arterial infusion (RAI), with no subsequent discomfort reported during follow-up. Subsequent evaluations at 4, 7, and 13 months demonstrated progressive lesion reduction. Three consecutive sputum smear tests (performed at intervals exceeding 6 months) yielded negative results for acid-fast bacilli, after which antituberculosis medications were discontinued per World Health Organization (WHO) criteria. This case demonstrates the complete diagnostic and therapeutic process of an isolated pancreatic tuberculosis patient. Through the combination of RAI and oral anti-tuberculosis medications, rapid symptom relief was achieved with favorable therapeutic outcomes. We share this experience to provide a reference for the treatment of such rare cases.

Open Access PDF

Concepts Keywords
Mycobacterium Administration, Oral
Rich Adult
Tuberculosis Angiography
Ultrasound Antitubercular Agents
Antitubercular Agents
Case report
Humans
Infusions, Intra-Arterial
Isoniazid
Isoniazid
Male
Mycobacterium tuberculosis
Pancreas
Pancreatic Diseases
Regional arterial infusion
Tomography, X-Ray Computed
Treatment Outcome
Tuberculosis
Tuberculosis

Semantics

Type Source Name
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Isoniazid
disease MESH neuroendocrine tumor
disease IDO history
disease MESH granuloma
drug DRUGBANK 5-amino-1 3 4-thiadiazole-2-thiol
disease IDO process
disease IDO symptom
pathway REACTOME Reproduction
disease MESH Infectious Diseases
drug DRUGBANK Coenzyme M
disease MESH Hemangioma
disease MESH weight loss
disease MESH jaundice
disease IDO blood
drug DRUGBANK Alkaline Phosphatase
drug DRUGBANK Rifampicin
disease MESH bile
disease MESH tumors
drug DRUGBANK L-Cysteine
drug DRUGBANK Sodium Chloride
disease MESH abnormalities
disease IDO intervention
drug DRUGBANK Cyanocobalamin
disease MESH complications
disease MESH peripheral neuritis
drug DRUGBANK Trestolone
drug DRUGBANK Pyrazinamide
drug DRUGBANK Ethambutol
drug DRUGBANK Methyprylon
disease MESH inflammation
disease MESH necrosis
disease MESH acute pancreatitis
pathway REACTOME Metabolism
disease MESH latent infections
disease MESH psychological distress
drug DRUGBANK Pancrelipase lipase
disease MESH infection
disease MESH bleeding
disease MESH chronic pancreatitis
disease MESH cystic neoplasms
disease MESH neoplastic processes
disease MESH misdiagnosis
disease IDO entity
disease IDO immunodeficiency
disease MESH Extrapulmonary tuberculosis
disease MESH Panic
disease MESH acquired immunodeficiency syndrome
disease MESH lymphadenopathy
disease IDO host
disease MESH Pancreatic Diseases

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *